首页> 外文会议>Hemophilia Symposium >Endogenous Thrombin Potential in Women with Recurrent Miscarriage and/or Repeated In-Vitro-Fertilization Failure
【24h】

Endogenous Thrombin Potential in Women with Recurrent Miscarriage and/or Repeated In-Vitro-Fertilization Failure

机译:具有复发流产和/或重复体外施肥失败的女性内源性凝血酶潜力

获取原文

摘要

Thrombophilia was implicated in the development of pregnancy complications [1-6], among these recurrent idiopathic pregnancy loss and repeated implantation failure in patients undergoing in-vitro-fertilization (IVF). The endogenous thrombin potential (ETP) has been reported to be increased during hyperco-agulable states [6-8], such as in hereditary thrombophilia and during the intake of oral contraceptives (OC). Aim of this pilot-study was to evaluate the ETP as a global coagulation screening test for a presumptive thrombophilic state in women with recurrent miscarriage and/or repeated implantation failure in patients undergoing IVF.
机译:血栓形成患有妊娠并发症的发育[1-6],在体外施肥(IVF)的患者中的这种经发性发作性妊娠丧失和重复的植入失败中。据报道,在高可炼油状态[6-8]期间,据报道,内源性凝血酶潜力(ETP)增加,例如遗传性血栓性血栓性血栓性和口服避孕药(OC)的摄入量。该试验研究的目的是评估ETP作为在接受IVF的患者中具有复发性流产和/或重复植入失败的妇女的推定血栓性状态的全球凝血筛选试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号